Skip to main content
. 2021 Jan 13;143(12):3515–3518. doi: 10.1093/brain/awaa398

Figure 1.

Figure 1

Increased O-GlcNAcylation (OGN) in dopamine transporter (DAT)-expressing neurons protects against Parkinson’s disease pathology.Left: Protective effects of increased O-GlcNAcylation. Right: Pathological effects of reduced O-GlcNAcylation.